Identification of epidermal growth factor (EGF), in an unknown pharmaceutical preparation suspected to contain insulin like growth factor 1 (IGF-1)

Drug Test Anal. 2017 May;9(5):831-837. doi: 10.1002/dta.2029. Epub 2016 Jul 8.

Authors

Celine Vanhee¹, Steven Janvier¹, Goedele Moens¹, Séverine Goscinny¹, Patricia Courselle¹, Eric Deconinck¹

Affiliation

¹ Division of Food, Medicines and Consumer Safety, Section Medicinal Products, Scientific Institute of Public Health (WIV-ISP), J. Wytsmansstraat14, B-1050, Brussels, Belgium.

PMID: 27390261
DOI: 10.1002/dta.2029

No abstract available

Publication types

Letter

MeSH terms

Amino Acid Sequence
Chromatography, Liquid
Epidermal Growth Factor / analysis*
Humans
Illicit Drugs / chemistry*
Insulin-Like Growth Factor I / analysis*
Mass Spectrometry
Pharmaceutical Preparations / chemistry
Recombinant Proteins / analysis

Substances

Illicit Drugs
Pharmaceutical Preparations
Recombinant Proteins
Epidermal Growth Factor
Insulin-Like Growth Factor I